STAT Plus: The FDA is finalizing its long-awaited rules for CBD
A version of this story first ran in D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
WASHINGTON — The Food and Drug Administration appears poised to release a long-awaited enforcement policy on cannabidiol, the marijauna-adjacent compound it has struggled to regulate for over a year.
Continue to STAT Plus to read the full story…
Read Original Article: STAT Plus: The FDA is finalizing its long-awaited rules for CBD »
